Published in Cancer Weekly, March 1st, 2005
The findings, which are preliminary and include the largest subset of patients enrolled in the phase I trial, were reported at the 2005 Gastrointestinal Cancers Symposium held by NCI investigator Jeffrey Farma, MD, a colleague of the study's principal investigator, H. Richard Alexander, MD, head of the NCI's Surgical Metabolism Section.
The expected average survival time for patients diagnosed with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.